Evasion of host immunity by the M protein
M蛋白逃避宿主免疫
基本信息
- 批准号:10204953
- 负责人:
- 金额:$ 61.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcuteAmino Acid SequenceAmino AcidsAntibodiesAntigensAttenuatedAutoimmuneBacteriaBindingBinding ProteinsBloodBuffaloesCell WallCollaborationsComplement 3bComplement Factor HComplexConsensusCrystallizationDepositionDevelopmentDiseaseFibrinogenGoalsHandHumanImmuneImmune systemImmunityImmunoglobulin Variable RegionInfectionKnowledgeLeadLifeMicrobiologyMorbidity - disease rateNatureOpsoninPatternPhagocytesPrevention strategyPropertyProteinsPublic HealthPublishingReportingResearch PersonnelResistanceRoleSeaStreptococcus pyogenesStructureSurfaceTestingTherapeuticVaccine DesignVaccinesVariantVirulenceVirulence FactorsWorkX-Ray Crystallographycomplement 4b-binding proteindesignmortalitymultiple myeloma M Proteinneutralizing antibodynovelnovel therapeuticspathogenic bacteriaprotein complexrecruitstreptococcal M proteinsuccessuptake
项目摘要
Group A Streptococcus (GAS, S. pyogenes) remains a major public health threat. This widespread Gram-
positive bacterial pathogen causes acute invasive diseases and gives rise to severe autoimmune sequelae,
and is responsible for morbidity and mortality on a global scale. An essential virulence factor of GAS, the
antigenically variable M protein, enables the bacterium to evade opsonophagocytic killing by the immune
system. The M protein confers this indispensable function of phagocyte resistance by recruiting specific soluble
human proteins to the GAS surface that block the deposition of the major opsonin C3b as well as antigen-
specific opsonic antibodies — namely, C4b-binding protein (C4BP), factor H (FH), and fibrinogen (Fg). In
some GAS strains, an M-like protein serves this function. More than 220 M types are known, and while most M
protein types bind C4BP, FH, or Fg, or a combination of these, no consensus binding motif is evident in M and
M-like proteins for any of these human proteins, except most recently for C4BP due to our breakthrough. This
is because the exposed portion of the M protein that recruits these anti-opsonic human proteins is
sequence variable. While inhibition of these interactions has been shown to render GAS sensitive to immune
killing, the lack of consensus binding motifs has hindered the therapeutic goal of targeting these
interactions. Our recent breakthrough, reported in Buffalo et al., offers a solution to this problem. In effect, we
found that hidden within the variable region of many M proteins is a three-dimensional (3D) pattern that
is conserved for binding C4BP. This 3D C4BP-binding pattern in the M protein is dispersed (or hidden)
within a sea of variable amino acids, which makes the 3D pattern nearly impossible to identify by primary
sequence alone. However with structural knowledge in hand as a guiding template, the 3D pattern becomes
easily recognizable within the primary sequence of many M types. We hypothesize that just as with C4BP,
hidden within the variable regions of M and M-like proteins are 3D patterns that are conserved for
binding FH and Fg. We propose to test this emerging theme of conservation hidden within variability by
unveiling potentially conserved FH- and Fg-binding 3D patterns in M and M-like proteins. We also propose to
complete our work on C4BP, as the 3D pattern we discovered and published in Buffalo et al. explains only
about a half of the set of M proteins implicated in C4BP binding. We propose to carry this out through X-ray
crystallography. We have an extensive record of success with crystallographic studies of the M protein, and
have obtained initial co-crystals of M proteins bound to C4BP, FH, and Fg. In each case, we will take
advantage of the highly detailed level of information provided by our structural studies to determine the precise
functional contributions of each of these interactions to virulence through our long-standing collaboration with
co-Investigator Victor Nizet (UCSD). The results from our studies will provide essential guidance in designing
anti-virulence strategies, and may have applications in the development of a broadly neutralizing GAS vaccine.
A群链球菌(GAS,化脓性链球菌)仍然是一个主要的公共卫生威胁。这种广泛存在的Gram-
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PARTHO GHOSH其他文献
PARTHO GHOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PARTHO GHOSH', 18)}}的其他基金
Selective infidelity in diversity-generating retroelements
产生多样性的逆向因素中的选择性不忠
- 批准号:
10526403 - 财政年份:2019
- 资助金额:
$ 61.75万 - 项目类别:
Selective infidelity in diversity-generating retroelements
产生多样性的逆向因素中的选择性不忠
- 批准号:
10305645 - 财政年份:2019
- 资助金额:
$ 61.75万 - 项目类别:
Selective infidelity in diversity-generating retroelements
产生多样性的逆向因素中的选择性不忠
- 批准号:
10063877 - 财政年份:2019
- 资助金额:
$ 61.75万 - 项目类别:
Selective infidelity in diversity-generating retroelements
产生多样性的逆向因素中的选择性不忠
- 批准号:
9896180 - 财政年份:2019
- 资助金额:
$ 61.75万 - 项目类别:
Diversity-Generation and Variable Protein Displays in Pathogens and Phage
病原体和噬菌体的多样性生成和可变蛋白质展示
- 批准号:
8788249 - 财政年份:2012
- 资助金额:
$ 61.75万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 61.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 61.75万 - 项目类别:
Standard Grant














{{item.name}}会员




